Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Proteogenomic Signatures Analysis In Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
- Status
- RECRUITING
- Phase
- PHASE2
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action
- Status
- RECRUITING
- Phase
- PHASE4
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
- Status
- COMPLETED
- Phase
- N/A
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
- Status
- RECRUITING
- Phase
- N/A
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
- Status
- RECRUITING
- Phase
- N/A
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1
[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Status
- RECRUITING
- Phase
- PHASE1